Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024ESMO OpenOpen Access

83P Integrating proteomic gene signature-based machine learning model predicts PD-1 monotherapy response in non-small cell lung cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

XZX. ZhangYWYangping WenCZCaicun Zhou

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e76a1eb6db6435876dfa2chttps://doi.org/10.1016/j.esmoop.2024.102662
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Network analysis predicts pembrolizumab response in advanced NSCLC with PD-L1 < 50%2026
  2. 2Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer2024 · 9 citations
  3. 3Blood-based molecular and cellular biomarkers of early response to neoadjuvant PD-1 blockade in patients with non-small cell lung cancer2024 · 5 citations
  4. 4Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients2024 · 5 citations
  5. 5Genomic correlates of the response to first-line PD-1 blockade plus chemotherapy in patients with advanced non-small-cell lung cancer2024